| Title : Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease - Koshy_2019_Psychopharmacology.(Berl)_236_1701 |
| Author(s) : Koshy Cherian A , Kucinski A , Wu R , de Jong IEM , Sarter M |
| Ref : Psychopharmacology (Berl) , 236 :1701 , 2019 |
| Abstract : |
| PubMedSearch : Koshy_2019_Psychopharmacology.(Berl)_236_1701 |
| PubMedID: 30607479 |
| Title : Antagonism of the 5-HT6 receptor - Preclinical rationale for the treatment of Alzheimer's disease - de Jong_2017_Neuropharmacol_125_50 |
| Author(s) : de Jong IEM , Mork A |
| Ref : Neuropharmacology , 125 :50 , 2017 |
| Abstract : |
| PubMedSearch : de Jong_2017_Neuropharmacol_125_50 |
| PubMedID: 28711518 |
| Title : The Serotonin Receptor 6 Antagonist Idalopirdine and Acetylcholinesterase Inhibitor Donepezil Have Synergistic Effects on Brain Activity-A Functional MRI Study in the Awake Rat - Ferris_2017_Front.Pharmacol_8_279 |
| Author(s) : Ferris CF , Kulkarni P , Yee JR , Nedelman M , de Jong IEM |
| Ref : Front Pharmacol , 8 :279 , 2017 |
| Abstract : |
| PubMedSearch : Ferris_2017_Front.Pharmacol_8_279 |
| PubMedID: 28659792 |